Winton Group’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
NTCM
CCM
SCM
RCMC
BCM
RIM
Winton Group's IRMD Position: Q1 2024 in Review
Winton Group sold out of iRadimed (IRMD) in Q1 2024, closing a stake of 8,264 shares — an estimated $392K sold.
Winton Group first reported a position in IRMD in Q4 2019 and held it in 11 quarters. The position peaked at $1.5M in Q2 2020. 126 funds tracked by Wall St. Rank hold IRMD as of Q1 2024.
- Winton Group reported no remaining iRadimed position as of Q1 2024 after selling out during the quarter.
- Winton Group sold 8,264 iRadimed shares in Q1 2024, an estimated $392K.
- Winton Group first reported a position in iRadimed in Q4 2019 and held it in 11 quarters.
- Winton Group's iRadimed position peaked at $1.5M in Q2 2020.
- 126 funds tracked by Wall St. Rank held iRadimed as of Q1 2024.
Based on Winton Group's 13F filing for Q1 2024, filed 14 May 2024.